HAINS Mycobacterium Tuberculosis First Line Drug Resistance Profile Test
Test Cost: AED 420.0
Symptoms, Diagnosis, and Test Details
The HAINS Mycobacterium Tuberculosis First Line Drug Resistance Profile Test is a molecular diagnostic test offered by DNA Labs UAE. This test is used to detect drug resistance mutations in the genes associated with resistance to first-line anti-tuberculosis drugs.
The test specifically targets the genes rpoB, katG, and inhA, which are associated with resistance to rifampicin and isoniazid, two commonly used first-line drugs for tuberculosis treatment.
The HAINS test utilizes polymerase chain reaction (PCR) technology to amplify and detect specific genetic regions of interest in the Mycobacterium tuberculosis genome. The amplified DNA is then hybridized with specific probes to identify drug resistance mutations.
The results of the test provide valuable information on the presence or absence of drug resistance mutations in the targeted genes. This information helps guide physicians in selecting appropriate antibiotics for tuberculosis treatment.
Test Components and Price
- Test Name: HAINS Mycobacterium Tuberculosis First Line Drug Resistance Profile Test
- Price: AED 420.0
Sample Condition and Submission
For this test, a sample of 2 mL (minimum 1 mL) of sputum, bronchoalveolar lavage, pleural aspirates, cerebrospinal fluid (CSF), body fluid, or cultured growth on appropriate media should be submitted in a sterile screw capped container. The sample should be placed in a sealed plastic bag and shipped refrigerated. Freezing the sample should be avoided.
Report Delivery
The sample for this test should be submitted on Tuesdays or Fridays by 11 am, and the report will be delivered on Thursdays or Mondays.
Test Method and Type
- Method: PCR, Line probe assay
- Test Type: Tuberculosis
Test Department and Doctor
- Test Department: Molecular Diagnostics
- Doctor: Physician
Pre Test Information
No special preparation is required before undergoing this test.
Conclusion
The HAINS Mycobacterium Tuberculosis First Line Drug Resistance Profile Test is an essential tool in the diagnosis and treatment of tuberculosis. By identifying drug resistance mutations, this test helps physicians make informed decisions regarding appropriate antibiotics for effective treatment.
| Test Name | HAINS MYCOBACTERIUM TUBERCULOSIS FIRST LINE DRUG RESISTANCE PROFILE Test |
|---|---|
| Components | |
| Price | 420.0 AED |
| Sample Condition | Submit 2 mL (1 mL min.) Sputum \/ Bronchoalveolar Lavage \/ Pleural aspirates \/ CSF \/ Body fluid OR Cultured growth on appropriate media in a sterile screw capped container in a sealed plastic bag. Ship refrigerated. DO NOT FREEZE |
| Report Delivery | SampleTue / Friby 11 am; Report Thu / Mon |
| Method | PCR, Line probe assay |
| Test type | Tuberculosis |
| Doctor | Physician |
| Test Department: | MOLECULAR DIAGNOSTICS |
| Pre Test Information | No special preparation required |
| Test Details | The HAINS Mycobacterium tuberculosis First Line Drug Resistance Profile Test is a molecular diagnostic test used to detect drug resistance mutations in the genes associated with resistance to first-line anti-tuberculosis drugs. This test specifically targets the genes rpoB, katG, and inhA, which are associated with resistance to rifampicin and isoniazid, two of the most commonly used first-line drugs for tuberculosis treatment. The HAINS test uses polymerase chain reaction (PCR) technology to amplify and detect specific genetic regions of interest in the Mycobacterium tuberculosis genome. The amplified DNA is then hybridized with specific probes to identify drug resistance mutations. The results of the test provide information on the presence or absence of drug resistance mutations in the targeted genes, helping to guide the selection of appropriate antibiotics for tuberculosis treatment. |
